Zimbabwe has begun rolling out a new long-acting injectable HIV-prevention drug, becoming one of the first countries in the world to introduce the breakthrough treatment in a national program. Health officials say the launch of Lenacapavir — the first twice-yearly injectable pre-exposure prophylaxis (PrEP) — marks a significant milestone in the country’s fight against HIV/AIDS, … Continue reading Zimbabwe Becomes First Country to Roll Out Twice-Yearly HIV Prevention Injection